1,749 followers
[REVIEW] Rare Opportunities: #CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases. Papasavva P, Kleanthous M, Lederer CW. Mol Diagn Ther. 2019-04-03. https://t.co/ziCH2QeibN https://t.co/Zn6v1pZUiN
[REVIEW] Rare Opportunities: #CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases. Papasavva P, Kleanthous M, Lederer CW. Mol Diagn Ther. 2019-04-03. https://t.co/ziCH2QeibN https://t.co/Zn6v1pZUiN